(PDF) Abnormal Expression of the ERG Transcription Factor

Abnormal Expression of the ERG Transcription Factor in Prostate Cancer Cells Activates Osteopontin

Molecular Cancer Research - United States

doi 10.1158/1541-7786.mcr-10-0537

Full Text

Abstract

Available in full text

Categories

Cancer Research

Molecular Biology

Date

June 13, 2011

Authors

M. Duterque-Coquillaud

Publisher

American Association for Cancer Research (AACR)

Related search

Ablation of the Oncogenic Transcription Factor ERG by Deubiquitinase Inhibition in Prostate Cancer

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Transcription Factor PU.1 Represses and Activates Gene Expression in Early T Cells by Redirecting Partner Transcription Factor Binding

Infectious Diseases

English

Transcription Factor YY1 Expression in Human Gastrointestinal Cancer Cells

International Journal of Oncology

Cancer Research

English

TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression

Journal of Cancer Science & Therapy

English

Osteopontin and MMP9: Associations With VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells

Cancer Research

English

Transcription Factor AP-1 Promotes Growth and Radioresistance in Prostate Cancer Cells

International Journal of Oncology

Cancer Research

English

ERG Rearrangement and Protein Expression in the Progression to Castration-Resistant Prostate Cancer

Prostate Cancer and Prostatic Diseases

Cancer Research

English

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer

Journal of the National Cancer Institute

Cancer Research

English

The Transcription Factor PlagL2 Activates MPL Transcription and Signaling in Hematopoietic Progenitor and Leukemia Cells

Cancer Research

English